浙富控股(002266.SZ):全資子公司被認定為2021年省重點企業研究院
格隆匯1月7日丨浙富控股(002266.SZ)公佈,根據浙江省科學技術廳近日發佈的《關於公佈2021年新認定省級企業研發機構名單的通知》,公司全資子公司浙江富春江水電設備有限公司(以下簡稱“浙富水電”)順利通過了浙江省科學技術廳的審核、評審以及公示等環節,被認定為“2021年省重點企業研究院”,研究院名稱為“浙江省富春江高端流體動力裝備重點企業研究院”。
“浙江省富春江高端流體動力裝備重點企業研究院”主要研究方向有:抽水蓄能水泵水輪發電機組、高海拔大容量水輪發電機組、第四代核反應堆主泵(液體金屬泵)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.